Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Westra TA"'
Autor:
Zeevat F; University Medical Center Groningen, Groningen, The Netherlands.; Health-Ecore, Zeist, The Netherlands., Simons JJM; University Medical Center Groningen, Groningen, The Netherlands. joost.j.simons@gsk.com.; GSK, Amersfoort, The Netherlands. joost.j.simons@gsk.com.; Market Access Department, GSK, Van Ash van Wijckstraat 55H, 3811, Amersfoort, The Netherlands. joost.j.simons@gsk.com., Westra TA; GSK, Amersfoort, The Netherlands., Wilschut JC; University Medical Center Groningen, Groningen, The Netherlands., van Sorge NM; Amsterdam University Medical Center, Amsterdam, The Netherlands., Boersma C; University Medical Center Groningen, Groningen, The Netherlands.; Health-Ecore, Zeist, The Netherlands.; Open University, Heerlen, The Netherlands., Postma MJ; University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Mar; Vol. 13 (3), pp. 481-499. Date of Electronic Publication: 2024 Feb 16.
Autor:
de Laat CR; Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Simons JJM; Market Access Department, GSK, Van Asch van Wijckstraat 55h, 3811 Amersfoort, The Netherlands., Westra TA; Market Access Department, GSK, Van Asch van Wijckstraat 55h, 3811 Amersfoort, The Netherlands., Hiligsmann M; Department of Health Services Research, CAPHRI, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Publikováno v:
Vaccine: X [Vaccine X] 2023 Jun 27; Vol. 14, pp. 100340. Date of Electronic Publication: 2023 Jun 27 (Print Publication: 2023).
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S177-S177
Autor:
Simons JJM; Market Access Department, GSK, Van Ash van Wijckstraat 55H, 3811 Amersfoort, the Netherlands.; Department of Health Sciences, University of Groningen, University Medical Center, Hanzeplein 1, 9713 GZ Groningen, the Netherlands., Westra TA; Market Access Department, GSK, Van Ash van Wijckstraat 55H, 3811 Amersfoort, the Netherlands., Postma MJ; Department of Health Sciences, University of Groningen, University Medical Center, Hanzeplein 1, 9713 GZ Groningen, the Netherlands.; Unit of Pharmacotherapy, -Epidemiology & -Economics, University of Groningen, Groningen Research Institute of Pharmacy, A Deusinglaan 1, 9713 AV Groningen, the Netherlands.; Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, P.O. Box 800, 9700 AV Groningen, the Netherlands.
Publikováno v:
Preventive medicine reports [Prev Med Rep] 2022 Jun 27; Vol. 28, pp. 101872. Date of Electronic Publication: 2022 Jun 27 (Print Publication: 2022).
Publikováno v:
In Value in Health January 2022 25(1) Supplement:S73-S73
Autor:
Andrianantoandro, Voahirana Tantely Annick1 (AUTHOR) anntantely@yahoo.fr, Audibert, Martine2 (AUTHOR) martine.audibert@uca.fr, Kesteman, Thomas3,4 (AUTHOR) tkestman@oucru.org, Ravolanjarasoa, Léonora3 (AUTHOR) leonoranjara@gmail.com, Randrianarivelojosia, Milijaona5,6 (AUTHOR) milijaon@hotmail.fr, Rogier, Christophe7,8 (AUTHOR) christophe.rogier@gmail.com
Publikováno v:
Cost Effectiveness & Resource Allocation. 12/3/2024, Vol. 22 Issue 1, p1-18. 18p.
Autor:
Simons JJM; Market Access Department, GSK, Huis ter Heideweg 62, 3705 Zeist, the Netherlands. Electronic address: joost.j.simons@gsk.com., Vida N; Value Evidence Department, GSK, Avenue Fleming 20, 1300 Wavre, Belgium. Electronic address: nora.x.vida@gsk.com., Westra TA; Market Access Department, GSK, Huis ter Heideweg 62, 3705 Zeist, the Netherlands. Electronic address: tjalke.t.westra@gsk.com., Postma MJ; Department of Health Sciences, University of Groningen, University Medical Center, Hanzeplein 1, 9713 GZ Groningen, the Netherlands; Unit of Pharmacotherapy, Epidemiology & Economics, University of Groningen, Groningen Research Institute of Pharmacy, A Deusinglaan 1, 9713 AV Groningen, the Netherlands; Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, P.O. Box 800, 9700 AV Groningen, the Netherlands. Electronic address: m.j.postma@rug.nl.
Publikováno v:
Vaccine [Vaccine] 2020 Jun 19; Vol. 38 (30), pp. 4687-4694. Date of Electronic Publication: 2020 May 23.
Publikováno v:
In Value in Health October-November 2017 20(9):A443-A443
Publikováno v:
In Value in Health November 2016 19(7):A416-A417
Autor:
Setiawan D; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Faculty of Pharmacy, University of Muhammadiyah Purwokerto, Purwokerto, Indonesia. Electronic address: d.didiksetiawan@gmail.com., Dolk FC; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands., Suwantika AA; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Faculty of Pharmacy, University of Padjadjaran, Bandung, Indonesia., Westra TA; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands., WIlschut JC; Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Postma MJ; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Institute of Science in Healthy Aging & healthcaRE (SHARE), University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Publikováno v:
Value in health regional issues [Value Health Reg Issues] 2016 May; Vol. 9, pp. 84-92. Date of Electronic Publication: 2016 Feb 19.